ÁLVARO
ANDRADES DELGADO
Researcher in the period 2023-2023
Institute Catalá Oncología
Barcelona, EspañaPublications in collaboration with researchers from Institute Catalá Oncología (1)
2021
-
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
Nature Communications, Vol. 12, Núm. 1